Skip to main content
EJNMMI Research
Figure 5 | EJNMMI Research

Figure 5

From: Evaluation of androgen-induced effects on the uptake of [18F]FDG, [11C]choline and [11C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model

Figure 5

μPET/μCT image of [18 F]FDG (a), [11 C]choline (b) and [11 C]acetate (c) uptake in a representative 22Rv1 tumour. SUVmax and SUVmeanTH were determined in the tumour before and after AD. They demonstrate the inhibition of tracer uptake (stabilised [18F]FDG uptake and decreased [11C]choline uptake under AD versus increased uptake in control). AD did not affect the uptake of [11C]acetate. μPET [18F]FDG data are scaled from 0 to 2 SUV, those of [11C]choline and [11C]acetate from 0 to 1 SUV. T, tumour.

Back to article page